Group B streptococci (GBS) are responsible for a large variety of human infections and have been recognized over the last few decades as a leading cause of perinatal disease worldwide (Farley 2001 , Weisner et al. 2004 . GBS are classified in serotypes (Ia, Ib and II-VIII) that occur in combination with different protein antigens (alpha, beta and rib) (Dmitriev et al. 2001) . Currently, serotypes Ia, III and V are the most common in many countries (Duarte et al. 2005 , Fluegge et al. 2005 , Bergseng et al. 2008 , Poyart et al. 2008 , von Both et al. 2008 .
Group B streptococci (GBS) are responsible for a large variety of human infections and have been recognized over the last few decades as a leading cause of perinatal disease worldwide (Farley 2001 , Weisner et al. 2004 . GBS are classified in serotypes (Ia, Ib and II-VIII) that occur in combination with different protein antigens (alpha, beta and rib) (Dmitriev et al. 2001) . Currently, serotypes Ia, III and V are the most common in many countries (Duarte et al. 2005 , Fluegge et al. 2005 , Bergseng et al. 2008 , Poyart et al. 2008 , von Both et al. 2008 .
Pulsed-field gel electrophoresis (PFGE), used to examine GBS strains, is a powerful technique employed for the classification of microorganisms after digestion of the genomic DNA by restriction enzymes (Benson & Ferrieri 2001 , Oliveira et al. 2005 , von Both et al. 2008 . Using polymerase chain reaction (PCR), Franken et al. (2001) suggested that the scpB and lmb genes (encoding c5a peptidase and laminin binding protein) must exist in GBS strains that infect humans. The hylB gene is frequently detected in these strains (Dore et al. 2003) . The bac and bca genes are present in 23% and 100% of type Ia strains, respectively (Maeland et al. 1997 (Maeland et al. , 2000 .
The lack of information on Ia Brazilian strains and the availability of DNA techniques led us to investigate the genetic make-up of type Ia GBS strains isolated in distinct regions of Brazil. Additionally, antimicrobial susceptibility was examined to better characterize these isolates.
MATERIALS AND METHODS
Bacterial strains -Forty-five human type Ia GBS strains derived from clinical specimens were obtained in Florianopolis, Santa Catarina (n = 3), a city located in the Southern Region of Brazil, in São Paulo, São Paulo (SP) (n = 1), and in Rio de Janeiro, Rio de Janeiro (n = 40), in the Southeast Region of the country. The source of one strain was unknown.
Isolates were obtained from 1981-2002 from public health laboratories, gynaecological clinics, hospitalsand universities. The clinical sources included urine (n = 16), oropharynx (n = 9), vagina (n = 5), anus (n = 2), lung (n = 2), placenta (n = 1), external ear canal (n = 1) and perineum (n = 1). The sources of eight specimens were unknown. A confirmatory identification of serotypes was carried out again by immunoprecipitation in agarose using sera produced in the research facilities of the authors and HCl antigenic extracts from the streptococci (Benchetrit et al. 1982) .
PFGE -PFGE was performed as previously described (Oliveira et al. 2005) . DNA was digested with the SmaI restriction enzyme (Amersham) and submitted to electrophoresis with a program as follows: switch time of 1-30 sec during 23 h, with a 120º angle, at a temperature of 11.3ºC and a voltage gradient of 6 V/cm. The lambda ladder PFGE marker kit (New England Biolabs) was used as a DNA size marker. Gels were stained with ethidium bromide and photographed under UV light. Criteria for analysis of the PFGE patterns were those originally suggested by Tenover et al. (1995) and used in our previous studies (Oliveira et al. 2005 (Oliveira et al. , 2006 . PCR -DNA extraction was performed according to Sambrook et al. (1989) . DNA fragments of the different GBS genes were amplified at a temperature of 53ºC. PCR-amplified products were run on agarose gels and stained with ethidium bromide. The 123-bp lambda ladder kit (Invitrogen) was used as a DNA size marker. A metabolic gene encoding the glucose 6-phosphateisomerase-1 was employed as a positive control in all reactions. Primers were designed by the authors and prepared by Promicro (SP) as follows: 5' -GTACCTTG-GTGCAAAAGCAG (forward) and 5' -GAGAAGTTT-GCTGATGTAGG (reverse; gene encoding the glucose 6-phosphate-isomerase-1); 5' -CTACAATTCCAGG-GAGTGCA (forward) and 5' -ACTTTCTTCCGTC-CACTTAG (reverse; bca, encodes alpha protein); 5' -AAGCAACTAGAAGAGGAAGC (forward) and 5' -TTCTGCTCTGGTGTTTTAGG (reverse; bac, encodes beta protein); 5' -CCTGCTAAGACTGCTGATAC (forward) and 5' -CATAAGCATAGTCGTAAGCC (reverse; scpB, encodes C5a peptidase); 5' -CACCAATCCCCA-CTCTACTA (forward) and 5' -TGTGTCAAACCATC-TATCAG (reverse; hylB, encodes hyaluronate lyase). One strain of Streptococcus pyogenes was used as a negative control. Two GBS strains obtained from humans, provided by Dr. L. M. Teixeira (Universidade Federal do Rio de Janeiro), were used as positive controls.
Antimicrobial susceptibility testing -Susceptibility to seven antimicrobial agents was examined by using the single-disk diffusion method and Clinical Laboratory Standards Institute guidelines (CLSI 2006) .
RESULTS
After digestion with SmaI, 34 electrophoretic profiles belonging to eight clusters (A -H) were observed for the 45 strains (Fig. 1) . Twenty-four of the strains belonged to the A cluster (A1-A16 profiles). Five isolates belonged to the B cluster (B1-B3 profiles), three belonged to the C cluster (C1 and C2 profiles), nine belonged to the D cluster (D1-D9 profiles) and each of the remaining four strains belonged to clusters E, F, G and H, respectively. The A1 profile was identified in a strain isolated in 1984 in Florianopolis and 18 years later in Rio de Janeiro. There is a distance of 1,150 km between these two locations. All strains were bac negative, hylB and scpB positive and 35 were bca negative. As expected, virulence genes were detected in control strains and the metabolic gene was detected in all reactions (Fig. 2) . In addition, all strains were sensitive to penicillin, vancomycin, clindamycin, erythromycin and chloramphenicol. Resistance to tetracycline was seen in 39 isolates and sensitivity was observed for five strains. Forty-three GBS strains were sensitive to rifampin. Intermediate susceptibilities to tetracycline and rifampin were observed for one and two strains, respectively. PFGE and virulence profiles, antimicrobial susceptibilities and the clinical sources of the strains are shown in Table. DISCUSSION Our data describing the molecular epidemiology of 45 Ia GBS strains isolated in Brazil show a remarkable clustering, with 24 isolates in cluster A. It is important to note that the strains were collected over a period of 21 years. There was no specific local or time clustering, as clusters were spread over the 21-year time period and were from all sources. Other researchers found a more enhanced genetic heterogeneity in strains of serotype Ia, which were isolated during a shorter period of time. Skjaervold et al. (2004) identified 10 different electrophoretic profiles among 12 strains isolated in 1999 and S  A11  01008  2001  unknown  RJ  -R  S  A12  88686  1988  vagina  RJ  -R  S  A13  02053  2002  urine  RJ  -R  S  A14  01009  2001  urine  RJ  -R  S  A14  01028  2001  vagina  RJ  -R  S  A14  01029  2001  urine  RJ  -R  I  A15  96027  1996  urine  RJ  -R  S  A16  02068  2002  unknown  RJ  -R  S  B1  90218  1990  lung  RJ  -S  S  B1  90220  1990  perineum  RJ  -R  S  B2  90222  1990  urine  RJ  -R  S  B3  85427  1985  pharynx  RJ  -I  S  B3  85685  1985  pharynx  RJ  -R  S  C1  91239  1991  pharynx  RJ  +  R  S  C1  91402  1991  pharynx  RJ  +  S  S  C2  91199  1991  pharynx  RJ  +  R  S  D1  90096  1990  pharynx  RJ  +  R  S  D2  02044  2002  urine  RJ  -R  S  D3  90352  1990  placenta  RJ  -S  S  D4  02008  2002  unknown  RJ  -R  S  D5  02016  2002  unknown  RJ  -R  S  D6  02035  2002  unknown  RJ  +  R  S  D7  01017  2001  urine  RJ  -S  S  D8  02067  2002  urine  RJ  -R  S  D9  02023  2002  urine  RJ  -R  S  E  89496  1989  pharynx  RJ  -R  S  F  90194  1990  urine  RJ  -R  S  G  83093  1983  anus  SC  -S  S  H  96028  1996 There was previously no data about the genetic diversity among serotype Ia Brazilian strains. A similar study was conducted by our research group to analyse strains of type II, III and V isolated in humans in the same geographic areas and period of time (Oliveira et al. 2005) . A predominant profile was clearly defined for each of these serotypes but was not identified in our Ia isolates, which instead displayed a slightly higher genetic heterogeneity than others.
The hylB and scpB genes were detected in all isolates. According to the literature, the hylB gene is uncommon in bovine GBS strains but is often present in human strains. Some authors even suggest that the presence of the scpB gene in human isolates is mandatory (Dmitriev et al. 2001 , Franken et al. 2001 ). However, Duarte et al. (2005) detected scpB in 97% of human isolates and Dore et al. (2003) described one hylB negative human strain. Ten of our strains carried the bca gene. According to the literature, between 30-55% of serotype Ia GBS human strains carry this bca gene (Dore et al. 2003 , Duarte et al. 2005 .
In the present study, none of the 45 streptococci carried the bac gene. This was also observed in the Brazilian isolates studied by Duarte et al. (2005) .
Variable susceptibilities of GBS to erythromycin and clindamycin (from 4-40%) are described in the literature (Hsueh et al. 2001 , Uh et al. 2001 , Díaz et al. 2008 . Simões et al. (2007) did not detect resistance to erythromycin and clindamycin among Ia isolates collected between 2003-2004 in São Paulo. We also did not detect resistance to these two antibiotics. Duarte et al. (2005) described some resistance to erythromycin (5%) among Ia strains collected between 2000-2001 in Rio de Janeiro. In the present report, susceptibility to other antimicrobial agents is in agreement with other data in the literature (Hsueh et al. 2001 , Uh et al. 2001 , Simões et al. 2007 .
Our data may suggest a relevant perpetuation and dissemination of cluster A throughout Brazil and may suggest the direction of further studies on this GBS serotype in geographical areas of the Southern Hemisphere, especially in developing countries.
